Chronos Archive seal
The Human Record

Richard Roundtree

Case HR-ML015-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
July 9, 1942 – October 24, 2023
Synthetic DOB
1942-07-09
Index visit
1993-09-29 at age 51
Synthetic MRN
HR-ML015-SYN-TD

Teaching objective: Men get breast cancer. Evaluate a new breast lump in a man of 51 promptly, without accepting an earlier history of gynecomastia as an explanation: examination that tells a firm, eccentric cancer from soft, central gynecomastia, same-week diagnostic mammography and ultrasound of both breasts and both axillae, and core biopsy of the mass and any abnormal node; ER, PR, and HER2 status; germline genetic testing and counseling for every man with breast cancer; surgical planning with a breast surgical oncologist; lymphedema prevention; and preparation for chemotherapy followed by tamoxifen, the preferred endocrine therapy for men, on the ASCO male breast cancer guideline, the NCCN breast guideline, and the CMID breast cancer monograph. His own public account of embarrassment and of keeping his treatment secret frames the teaching on the stigma that delays men's care.

Historical timeline

DateEventClaims
July 9, 1942Born in New Rochelle, New York.CLM-0001
About 1955 (age 13)Breast enlargement (gynecomastia) in adolescence, as he later described it.CLM-0003
End of September 1993Finds a lump under the left nipple; biopsy shows breast cancer.CLM-0003, CLM-0004
October 1993Mastectomy (single or double, accounts differ) with spread to the lymph nodes; then six months of chemotherapy.CLM-0005, CLM-0006, CLM-0007
2000Speaks publicly about his breast cancer for the first time.CLM-0008
October 2019Describes in a television interview his embarrassment at the diagnosis and the lasting numbness under his left arm.CLM-0004, CLM-0009
October 24, 2023Died at his home in Los Angeles, aged 81.CLM-0010

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Richard Roundtree was born on July 9, 1942, in New Rochelle, New York. confirmed Richard Roundtree supports
Landrum J Jr. Richard Roundtree, 'Shaft' action hero, dies at 81 (Associated Press) supports
D Roundtree was an actor best known as the private detective John Shaft in films beginning in the early 1970s, and is described as the first Black action hero. confirmed Landrum J Jr. Richard Roundtree, 'Shaft' action hero, dies at 81 (Associated Press) supports
D Roundtree told PEOPLE that at the end of September 1993, in the shower, he felt a lump under his left nipple, 'the size of a lima bean'; he was not overly concerned at first, because at 13 he had had gynecomastia (breast enlargement), and he 'just chalked it up to that.'
His own public account; the attribution of a new lump to earlier gynecomastia is the delay the synthetic episode teaches against.
confirmed Hannah J, Fisher C. How Richard Roundtree Spoke Up About His Breast Cancer Diagnosis Years Before Death (Exclusive). PEOPLE, republished by Yahoo News supports
D In a 2019 television interview Roundtree said he found the lump in the shower while working in Costa Rica in 1993 and saw his doctor after returning to Los Angeles a week later; the doctor biopsied it and four or five days later told him he had breast cancer. Asked whether he had felt shame, he answered 'Embarrassment,' and he said men 'are so cavalier about their health issues and want to sweep it under the rug.'
His own account of the stigma. It adds a location and a week's gap that the PEOPLE account does not give; the two are not in conflict on the diagnosis.
confirmed 'Shaft' star Richard Roundtree opens up about his battle with breast cancer. Extra supports
D Roundtree told PEOPLE that his physician called him four or five days after the visit to tell him in person; that a day or two later he was in the hospital for a modified radical mastectomy, which removed the complete breast from the sternum to the underarm, including the nipple and areola; and that the cancer had spread to the lymph nodes. The same article describes the operation as removing his left breast.
His own account of a single-sided operation on the left. See CLM-0006 for the conflicting reports.
confirmed Hannah J, Fisher C. How Richard Roundtree Spoke Up About His Breast Cancer Diagnosis Years Before Death (Exclusive). PEOPLE, republished by Yahoo News supports
D Sources differ on the extent of the operation: his own account in PEOPLE describes a modified radical mastectomy of the left breast, while the Associated Press obituary and an encyclopedia article (citing a 2001 USA Today interview) say he underwent a double mastectomy.
The conflict is recorded and not resolved. Neither account is preferred, and the synthetic record does not settle whether the right breast was removed.
disputed Hannah J, Fisher C. How Richard Roundtree Spoke Up About His Breast Cancer Diagnosis Years Before Death (Exclusive). PEOPLE, republished by Yahoo News supports
Landrum J Jr. Richard Roundtree, 'Shaft' action hero, dies at 81 (Associated Press) supports
Richard Roundtree supports
Evans-Biermann R. Richard Roundtree 'Knows the Score' on cancer. USA Today, September 18, 2001 context
D Roundtree said that after the operation he had six months of chemotherapy, that he lost 18 pounds, and that 'the nausea is something you never, ever forget.'
Treatment he made public; the regimen was not made public.
confirmed Hannah J, Fisher C. How Richard Roundtree Spoke Up About His Breast Cancer Diagnosis Years Before Death (Exclusive). PEOPLE, republished by Yahoo News supports
Richard Roundtree supports
D Roundtree said he kept his treatment secret for fear it would end his film career, keeping his undershirt on during the physical examinations required for each film; that 'nobody ever knew I was even in the hospital'; that about six years after treatment, when he had been given the all-clear, he decided to speak up, telling PEOPLE in 2000; and that he was 'not embarrassed,' urging men to speak about breast cancer.
The secrecy and the later advocacy at the center of the teaching on stigma.
confirmed Hannah J, Fisher C. How Richard Roundtree Spoke Up About His Breast Cancer Diagnosis Years Before Death (Exclusive). PEOPLE, republished by Yahoo News supports
D In the 2019 interview he said that the left side of his chest had no feeling under the arm.
A lasting effect he described publicly; numbness under the arm after axillary surgery is common.
confirmed 'Shaft' star Richard Roundtree opens up about his battle with breast cancer. Extra supports
D Roundtree died at his home in Los Angeles on October 24, 2023, aged 81; his longtime manager said he had been diagnosed with pancreatic cancer.
History only. The pancreatic cancer is not part of the synthetic episode, and no link to the breast cancer is asserted.
confirmed Landrum J Jr. Richard Roundtree, 'Shaft' action hero, dies at 81 (Associated Press) supports
Richard Roundtree supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Invasive ductal carcinoma of the left male breast, central (retroareolar) portion, presenting as a 1.5 cm firm, painless lump eccentric to the left nipple with a palpable left axillary node; core biopsy: grade 3, ER positive, PR positive, HER2 negative, with metastatic carcinoma in the node; clinical stage IIA (cT1c cN1 M0); synthetic modern detail linked to his publicly disclosed breast cancer active confirmed both_with_link CLM-0003, CLM-0005, CLM-0006
S Estrogen receptor-positive status of the breast cancer active confirmed active CLM-0003, CLM-0005
S New firm, painless lump of about 1.5 cm just off the left nipple, with a palpable left axillary node; suspected breast cancer, imaging and core biopsy booked resolved confirmed active CLM-0003, CLM-0005

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1993-09-29 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1993-10-05 Hemoglobin [Mass/volume] in Blood 14.8 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1993-10-05 Leukocytes [#/volume] in Blood by Automated count 6.6 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1993-10-05 Neutrophils [#/volume] in Blood by Automated count 3.9 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 1993-10-05 Platelets [#/volume] in Blood by Automated count 246 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1993-10-05 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1993-10-05 Potassium [Moles/volume] in Serum or Plasma 4.1 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1993-10-05 Creatinine [Mass/volume] in Serum or Plasma 1.02 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1993-10-05 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1988)/1.73 sq M 89 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1993-10-05 Glucose [Mass/volume] in Serum or Plasma 92 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1993-10-05 Calcium [Mass/volume] in Serum or Plasma 9.5 mg/dL
Reference 8.6-10.3 mg/dL
http://loinc.org · 17861-6
S 1993-10-05 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1993-10-05 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 1993-10-05 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 71 U/L
Reference 40-129 U/L
http://loinc.org · 6768-6
S 1993-10-05 Bilirubin.total [Mass/volume] in Serum or Plasma 0.7 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1993-10-05 Albumin [Mass/volume] in Serum or Plasma 4.4 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 1993-10-05 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 5 http://loinc.org · 44261-6
S 1993-10-20 Hemoglobin [Mass/volume] in Blood 13.9 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1993-10-20 Leukocytes [#/volume] in Blood by Automated count 7 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 1993-10-20 Neutrophils [#/volume] in Blood by Automated count 4.3 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 1993-10-20 Platelets [#/volume] in Blood by Automated count 281 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 1993-10-20 Creatinine [Mass/volume] in Serum or Plasma 0.98 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1993-10-20 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1988)/1.73 sq M 93 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1993-10-20 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1993-10-20 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 1993-10-20 Albumin [Mass/volume] in Serum or Plasma 4.3 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 1993-10-20 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 6 http://loinc.org · 44261-6
S 1993-10-27 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1993-10-27 Total score [AUDIT-C] 2 http://loinc.org · 75626-2
S 1993-10-27 Cholesterol [Mass/volume] in Serum or Plasma 186 mg/dL
Reference <=200 mg/dL
http://loinc.org · 2093-3
S 1993-10-27 Cholesterol in HDL [Mass/volume] in Serum or Plasma 56 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 1993-10-27 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 112 mg/dL
Reference <=129 mg/dL
http://loinc.org · 13457-7
S 1993-10-27 Triglyceride [Mass/volume] in Serum or Plasma 90 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1993-10-27 Hemoglobin A1c/Hemoglobin.total in Blood 5.3%
Reference <=5.6%
http://loinc.org · 4548-4

Synthetic vital signs

DateMeasureResultLOINCGrade
1993-09-29Body height188 cm8302-2S
1993-09-29Body weight86 kg29463-7S
1993-09-29Body mass index (BMI) [Ratio]24.3 kg/m239156-5S
1993-09-29Systolic blood pressure128 mm[Hg]8480-6S
1993-09-29Diastolic blood pressure80 mm[Hg]8462-4S
1993-09-29Heart rate74 /min8867-4S
1993-09-29Respiratory rate14 /min9279-1S
1993-09-29Body temperature36.7 Cel8310-5S
1993-09-29Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1993-10-05Body height188 cm8302-2S
1993-10-05Body weight85.6 kg29463-7S
1993-10-05Body mass index (BMI) [Ratio]24.2 kg/m239156-5S
1993-10-05Systolic blood pressure134 mm[Hg]8480-6S
1993-10-05Diastolic blood pressure82 mm[Hg]8462-4S
1993-10-05Heart rate82 /min8867-4S
1993-10-05Respiratory rate16 /min9279-1S
1993-10-05Body temperature36.8 Cel8310-5S
1993-10-05Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1993-10-20Body height188 cm8302-2S
1993-10-20Body weight84.8 kg29463-7S
1993-10-20Body mass index (BMI) [Ratio]24 kg/m239156-5S
1993-10-20Systolic blood pressure126 mm[Hg]8480-6S
1993-10-20Diastolic blood pressure78 mm[Hg]8462-4S
1993-10-20Heart rate76 /min8867-4S
1993-10-20Respiratory rate14 /min9279-1S
1993-10-20Body temperature36.7 Cel8310-5S
1993-10-20Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
1993-10-27Body height188 cm8302-2S
1993-10-27Body weight85 kg29463-7S
1993-10-27Body mass index (BMI) [Ratio]24 kg/m239156-5S
1993-10-27Systolic blood pressure124 mm[Hg]8480-6S
1993-10-27Diastolic blood pressure78 mm[Hg]8462-4S
1993-10-27Heart rate72 /min8867-4S
1993-10-27Respiratory rate14 /min9279-1S
1993-10-27Body temperature36.6 Cel8310-5S
1993-10-27Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Tissue diagnosis within one week of presentation1993-10-05completedImaging and core biopsy the day after presentation; diagnosis explained on the sixth day
Curative surgery within two weeks of diagnosis, with lymphedema prevention taught1993-10-20completedMastectomy and axillary dissection two days after the diagnosis; clear margins; arm exercises and risk reduction taught
Complete germline genetic testing with counseling before chemotherapy starts1993-10-27activePanel sent on the day of diagnosis; result not yet back at the end of the episode
Be ready to start adjuvant chemotherapy within six weeks of surgery: echocardiogram, hepatitis B screening, vaccines, and dental review done1993-10-27activeEchocardiogram normal; vaccines and hepatitis B screening at the preventive visit; dental review booked; first cycle scheduled

Interventions

InterventionStatusGuideline
Urgent surgical oncology (breast) consultation for a suspected breast cancer with an abnormal left axillary node, core biopsy pending, to plan the operation and the axillacompletedGL-ASCO-MBC-2020, GL-NCCN-BREAST-2025
Same-week diagnostic mammography and ultrasound of both breasts and both axillae, and ultrasound-guided core biopsy of the mass and the abnormal node with ER, PR, and HER2 testingcompletedGL-ASCO-MBC-2020, GL-NCCN-BREAST-2025
Genetic counseling and germline multigene panel testing (including BRCA2, BRCA1, PALB2, CHEK2, and ATM), as for every man with breast cancer, with a letter for relatives if a variant is foundcompletedGL-ASCO-MBC-2020, GL-ASCO-SSO-GERM-2024
Mastectomy with axillary lymph node dissection, then shoulder exercises and lymphedema risk reduction with arm measurements at each visitcompletedGL-NCCN-BREAST-2025, GL-ACS-ASCO-SURV-2016
Adjuvant chemotherapy given by medical oncology (doxorubicin and cyclophosphamide every three weeks for four cycles, then weekly paclitaxel for twelve weeks, about six months), after a baseline echocardiogram, hepatitis B screening, vaccines, and a dental review; radiation oncology review of post-mastectomy radiation after chemotherapycompletedGL-NCCN-BREAST-2025, GL-ASCO-CARDIO-2017, GL-ASCO-HBV-2020
Tamoxifen after chemotherapy for at least five years, the first-choice endocrine therapy for men, with venous thromboembolism, mood, hot flash, sexual side effect, and adherence checks at every visitcompletedGL-ASCO-MBC-2020, GL-CMID-2026
Distress screening at each visit, plain information that men get breast cancer, confidential handling of his diagnosis at work, and the offer of a peer-support group for men with breast cancercompletedGL-ACS-ASCO-SURV-2016, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Hannah J, Fisher C. How Richard Roundtree Spoke Up About His Breast Cancer Diagnosis Years Before Death (Exclusive). PEOPLE, republished by Yahoo News PEOPLE (via Yahoo News) other
SRC-0002 Landrum J Jr. Richard Roundtree, 'Shaft' action hero, dies at 81 (Associated Press) WJLA (Associated Press) other
SRC-0003 'Shaft' star Richard Roundtree opens up about his battle with breast cancer. Extra Extra (Warner Bros.) other
SRC-0004 Richard Roundtree Wikipedia other
SRC-0005 Evans-Biermann R. Richard Roundtree 'Knows the Score' on cancer. USA Today, September 18, 2001 USA Today other
SRC-0006 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the upfront surgery for cN1 disease, the chemotherapy choice, and the open question of post-mastectomy radiation.
provenance reviewnot_startedRecent-death rule: only what Roundtree said publicly (a 2000 PEOPLE interview as republished, a 2019 television interview) and the facts in his obituaries are used. The single versus double mastectomy conflict is recorded and not resolved. The physicians named in the PEOPLE article are not named in the record.
safe messaging reviewnot_startedBreast cancer in a man is described plainly; his embarrassment is recorded as his own public account and answered with information and support, never as a framing of the diagnosis; no behavioral-health diagnosis; the pancreatic cancer and death are recorded as history only.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.